Orionis Biosciences
Inge Hoebeke has a diverse work experience in different scientific roles. Inge started their career as a Research Scientist at the University of Florida in 2000. Inge then moved to Ghent University, where they worked as a PhD student from 2001 to 2006. Following their PhD, they worked as a Postdoctoral Researcher at the Free University Brussels from 2006 to 2008, and then at Ghent University again from 2009 to 2013. In 2014, Inge joined PharmaVize as a Technical-Regulatory Writer for a year before joining AgroSavfe NV. At AgroSavfe NV, they worked as a Scientist from 2015 to 2017. Most recently, in 2018, they joined Orionis Biosciences as a Scientist.
Inge Hoebeke obtained a PhD in Medical Sciences from Ghent University, where they pursued their studies from 1995 to 2000. Additionally, during the same period, they also completed their degree in Bio-engineering with a focus on Cell and Gene Biotechnology at Ghent University.
This person is not in any offices
Orionis Biosciences
1 followers
Orionis Biosciences operates in the healthcare industry focusing on the biotechnology business and innovation.The company is an early-stage drug discovery and development biotechnology company fueled by a suite of disruptive technologies to advance innovative medicines for the treatment of diseases with high unmet medical needs – with an initialinternal focus in oncology and immunotherapies.Orionis Biosciences has research facilities in the Boston area (Headquarters in Waltham, MA, USA) and Ghent (Belgium), and is operated by a world class team of entrepreneurs, scientists and transatlantic network of investors, in concert with strategic research and development collaborations. The latter includes collaborations with VIB (Belgium), Orionis Biosciences co-founding institution.